Update on neuropathic pain treatment for trigeminal neuralgia

References

1. ↵
   1. Adams F

   , ed (1856) The extant works of Aretaeus, the Cappadocian (Sydenhem Society, London (UK)).
2. ↵
   (2004) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24, 9–160.
3. ↵
   1. Childs AM,
   2. Meaney JF,
   3. Ferrie CD,
   4. Holland PC

   (2000) Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports. Arch Dis Child 82, 311–315.
4. ↵
   1. Dieleman JP,
   2. Kerklaan J,
   3. Huygen FJ,
   4. Bouma PA,
   5. Sturkenboom MC

   (2008) Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137, 681–688.
5. 1. Koopman JS,
   2. Dieleman JP,
   3. Huygen FJ,
   4. de Mos M,
   5. Martin CG,
   6. Sturkenboom MC

   (2009) Incidence of facial pain in the general population. Pain 147, 122–127.
6. ↵
   1. Katusic S,
   2. Williams DB,
   3. Beard CM,
   4. Bergstralh EJ,
   5. Kurland LT

   (1991) Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 10, 276–281.
7. ↵
   1. Hall GC,
   2. Carroll D,
   3. McQuay HJ

   (2008) Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study 2002-2005. BMC Fam Pract 9, 26.
8. ↵
   1. Wiffen PJ,
   2. McQuay HJ,
   3. Moore RA

   (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 3, CD005451.
9. ↵
   1. Bennetto L,
   2. Patel NK,
   3. Fuller G

   (2007) Trigeminal neuralgia and its management. BMJ 334, 201.
10. ↵
    1. Wiffen PJ,
    2. Derry S,
    3. Moore RA,
    4. McQuay HJ

    (2011) Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev 1, CD005451.
11. ↵
    1. Gronseth G,
    2. Cruccu G,
    3. Alksne J,
    4. Argoff C,
    5. Brainin M,
    6. Burchiel K,
    7. et al.

    (2008) Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 71, 1183–1190.
12. ↵
    1. Devor M,
    2. Amir R,
    3. Rappaport ZH

    (2002) Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18, 4–13.
13. ↵
    1. Zakrzewska JM,
    2. Linskey ME

    (2009) Trigeminal neuralgia. BMJ Clin Evid 2009, 1207.
14. ↵
    1. Love S,
    2. Coakham HB

    (2001) Trigeminal neuralgia: pathology and pathogenesis. Brain 124, 2347–2360.
15. ↵
    1. Hassan S,
    2. Khan NI,
    3. Sherwani OA,
    4. Bhatt W,
    5. Asif S

    (2013) Trigeminal neuralgia: an overview of literature with emphasis on medical management. Int Research J Pharmcol 3, 235–238.
16. ↵
    1. El Otmani H,
    2. Moutaouakil F,
    3. Fadel H,
    4. Slassi I

    (2008) [Familial trigeminal neuralgia]. Rev Neurol (Paris) 164, 384–387, French.
17. ↵
    1. Ali FM,
    2. Prasant M,
    3. Pai D,
    4. Aher VA,
    5. Kar S,
    6. Safiya T

    (2012) Peripheral neurectomies: A treatment option for trigeminal neuralgia in rural practice. J Neurosci Rural Pract 3, 152–157.
18. 1. Cruccu G,
    2. Truini A

    (2013) Refractory trigeminal neuralgia. Non-surgical treatment options. CNS Drugs 27, 91–96.
19. ↵
    1. Nurmikko TJ,
    2. Eldridge PR

    (2001) Trigeminal neuralgia--pathophysiology, diagnosis and current treatment. Br J Anaesth 87, 117–132.
20. ↵
    1. Cruccu G,
    2. Gronseth G,
    3. Alksne J,
    4. Argoff C,
    5. Brainin M,
    6. Burchiel K,
    7. et al.

    (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15, 1013–1028.
21. ↵
    1. Wiffen P,
    2. Collins S,
    3. McQuay H,
    4. Carroll D,
    5. Jadad A,
    6. Moore A

    (2005) Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 3, CD001133.
22. ↵
    1. Wiffen PJ,
    2. McQuay HJ,
    3. Edwards JE,
    4. Moore RA

    (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 3, CD005452.
23. ↵
    1. Zakrzewska JM,
    2. Lopez BC

    (2005) Trigeminal neuralgia. Clin Evid 14, 1669–1677.
24. ↵
    1. Granger P,
    2. Biton B,
    3. Faure C,
    4. Vige X,
    5. Depoortere H,
    6. Graham D,
    7. et al.

    (1995) Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol 47, 1189–1196.
25. ↵
    1. Joffroy A,
    2. Levivier M,
    3. Massager N

    (2001) Trigeminal neuralgia. Pathophysiology and treatment. Acta Neurol Belg 101, 20–25.
26. ↵
    1. Obermann M

    (2010) Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord 3, 107–115.
27. ↵
    1. Devor M,
    2. Wood I,
    3. Sharav Y,
    4. Zakrzewska JM

    (2008) Trigeminal neuralgia during sleep. Pain Pract 8, 263–268.
28. ↵
    1. Ferrell PB Jr.,
    2. McLeod HL

    (2008) Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9, 1543–1546.
29. ↵
    1. George M,
    2. Selvarajan S,
    3. Indumathi C

    (2011) Drug therapy for trigeminal neuralgia. e-Journal of Dentistry 1, 28–31.
30. ↵
    1. Martinez W,
    2. Ingenito A,
    3. Blakeslee M,
    4. Barkley GL,
    5. McCague K,
    6. D’Souza J

    (2006) Efficacy, safety, and tolerability of oxcarbazepine monotherapy. Epilepsy Behav 9, 448–456.
31. ↵
    1. Beydoun A

    (2000) Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 20, 152S–158S.
32. ↵
    1. Fromm GH,
    2. Terrence CF,
    3. Chattha AS

    (1984) Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 15, 240–244.
33. 1. Lechin F,
    2. van der Dijs B,
    3. Lechin ME,
    4. Amat J,
    5. Lechin AE,
    6. Cabrera A,
    7. et al.

    (1989) Pimozide therapy for trigeminal neuralgia. Arch Neurol 46, 960–963.
34. ↵
    1. Zakrzewska JM,
    2. Chaudhry Z,
    3. Nurmikko TJ,
    4. Patton DW,
    5. Mullens EL

    (1997) Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73, 223–230.
35. ↵
    1. Lunardi G,
    2. Leandri M,
    3. Albano C,
    4. Cultrera S,
    5. Fracassi M,
    6. Rubino V,
    7. et al.

    (1997) Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48, 1714–1717.
36. ↵
    1. Wiffen PJ,
    2. Rees J

    (2007) Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2, CD006044.
37. ↵
    1. Fromm GH,
    2. Terrence CF,
    3. Chattha AS,
    4. Glass JD

    (1980) Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol 37, 768–771.
38. ↵
    1. Parekh S,
    2. Shah K,
    3. Kotdawalla H

    (1989) Baclofen in carbamazepine resistant trigeminal neuralgia - a double-blind clinical trial. Cephalalgia 9, 392–393.
39. ↵
    1. Leandri M

    (2003) Therapy of trigeminal neuralgia secondary to multiple sclerosis. Expert Rev Neurother 3, 661–671.
40. ↵
    1. Zakrzewska JM

    (2010) Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother 11, 1239–1254.
41. ↵
    1. Cheshire WP Jr.

    (2002) Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain 3, 137–142.
42. ↵
    1. Serpell MG,
    2. Neuropathic pain study group

    (2002) Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 99, 557–566.
43. ↵
    1. Khan OA

    (1998) Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51, 611–614.
44. ↵
    1. Backonja M,
    2. Glanzman RL

    (2003) Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 25, 81–104.
45. ↵
    1. Rodríguez MJ,
    2. Díaz S,
    3. Vera-Llonch M,
    4. Dukes E,
    5. Rejas J

    (2007) Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. Curr Med Res Opin 23, 2585–2596.
46. ↵
    1. Obermann M,
    2. Yoon MS,
    3. Sensen K,
    4. Maschke M,
    5. Diener HC,
    6. Katsarava Z

    (2008) Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28, 174–181.
47. ↵
    1. Domingues RB,
    2. Kuster GW,
    3. Aquino CC

    (2007) Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr 65, 792–794.
48. ↵
    1. Wang QP,
    2. Bai M

    (2011) Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis. CNS Drugs 25, 847–857.
49. ↵
    1. Jorns TP,
    2. Johnston A,
    3. Zakrzewska JM

    (2009) Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol 16, 740–744.
50. ↵
    1. Mitsikostas DD,
    2. Pantes GV,
    3. H Avramidis TG,
    4. Karageorgiou KE,
    5. Gatzonis SD,
    6. Stathis PG,
    7. et al.

    (2010) An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. Headache 50, 1371–1377.
51. ↵
    1. Brodie MJ,
    2. Perucca E,
    3. Ryvlin P,
    4. Ben-Menachem E,
    5. Meencke HJ,
    6. Levetiracetam Monotherapy Study Group

    (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68, 402–408.
52. ↵
    1. Frampton JE

    (2012) OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine. Drugs 72, 825–845.
53. ↵
    1. Porta M,
    2. Camerlingo M

    (2005) Headache and botulinum toxin. J Headache Pain 6, 325–327.
54. ↵
    1. Aoki KR

    (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26, 785–793.
55. ↵
    1. Hu Y,
    2. Guan X,
    3. Fan L,
    4. Li M,
    5. Liao Y,
    6. Nie Z,
    7. et al.

    (2013) Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain 14, 72.
56. ↵
    1. Wu CJ,
    2. Lian YJ,
    3. Zheng YK,
    4. Zhang HF,
    5. Chen Y,
    6. Xie NC,
    7. et al.

    (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32, 443–450.
57. ↵
    1. Piovesan EJ,
    2. Teive HG,
    3. Kowacs PA,
    4. Della Coletta MV,
    5. Werneck LC,
    6. Silberstein SD

    (2005) An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65, 1306–1308.
58. ↵
    1. Bohluli B,
    2. Motamedi MH,
    3. Bagheri SC,
    4. Bayat M,
    5. Lassemi E,
    6. Navi F,
    7. et al.

    (2011) Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111, 47–50.
59. 1. Zúñiga C,
    2. Díaz S,
    3. Piedimonte F,
    4. Micheli F

    (2008) Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr 66, 500–503.
60. 1. Türk U,
    2. Ilhan S,
    3. Alp R,
    4. Sur H

    (2005) Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 28, 161–162.
61. ↵
    1. Borodic GE,
    2. Acquadro MA

    (2002) The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3, 21–27.
62. ↵
    1. McCleane GJ

    (1999) Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg 89, 985–988.
63. 1. Cheshire WP

    (2001) Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage 21, 506–510.
64. 1. Kanai A,
    2. Suzuki A,
    3. Kobayashi M,
    4. Hoka S

    (2006) Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth 97, 559–563.
65. 1. Kanai A,
    2. Saito M,
    3. Hoka S

    (2006) Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache 46, 577–582, discussion 583-584.
66. ↵
    1. Yang M,
    2. Zhou M,
    3. He L,
    4. Chen N,
    5. Zakrzewska JM

    (2011) Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev 1, CD004029.
67. ↵
    1. Hodaie M,
    2. Coello AF

    (2013) Advances in the management of trigeminal neuralgia. J Neurosurg Sci 57, 13–21.
68. ↵
    1. Pollock BE

    (2012) Surgical management of medically refractory trigeminal neuralgia. Curr Neurol Neurosci Rep 12, 125–131.
69. ↵
    1. Bohnstedt BN,
    2. Tubbs RS,
    3. Cohen-Gadol AA

    (2012) The use of intraoperative navigation for percutaneous procedures at the skull base including a difficult-to-access foramen ovale. Neurosurgery 70, 177–180.
70. ↵
    1. Udupi BP,
    2. Chouhan RS,
    3. Dash HH,
    4. Bithal PK,
    5. Prabhakar H

    (2012) Comparative evaluation of percutaneous retrogasserian glycerol rhizolysis and radiofrequency thermocoagulation techniques in the management of trigeminal neuralgia. Neurosurgery 70, 407–412, discussion 412-413.
71. ↵
    1. Koopman JS,
    2. de Vries LM,
    3. Dieleman JP,
    4. Huygen FJ,
    5. Stricker BH,
    6. Sturkenboom MC

    (2011) A nationwide study of three invasive treatments for trigeminal neuralgia. Pain 152, 507–513.
72. ↵
    1. Gorgulho AA,
    2. De Salles AA

    (2006) Impact of radiosurgery on the surgical treatment of trigeminal neuralgia. Surg Neurol 66, 350–356.
73. ↵
    1. Sheehan J,
    2. Pan HC,
    3. Stroila M,
    4. Steiner L

    (2005) Gamma knife surgery for trigeminal neuralgia: outcomes and prognostic factors. J Neurosurg 102, 434–441.
74. ↵
    1. Petit JH,
    2. Herman JM,
    3. Nagda S,
    4. DiBiase SJ,
    5. Chin LS

    (2003) Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes. Int J Radiat Oncol Biol Phys 56, 1147–1153.
75. 1. Régis J,
    2. Metellus P,
    3. Hayashi M,
    4. Roussel P,
    5. Donnet A,
    6. Bille-Turc F

    (2006) Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia. J Neurosurg 104, 913–924.
76. ↵
    1. Lopez BC,
    2. Hamlyn PJ,
    3. Zakrzewska JM

    (2004) Stereotactic radiosurgery for primary trigeminal neuralgia: state of the evidence and recommendations for future reports. J Neurol Neurosurg Psychiatry 75, 1019–1024.
77. ↵
    1. Kondziolka D,
    2. Zorro O,
    3. Lobato-Polo J,
    4. Kano H,
    5. Flannery TJ,
    6. Flickinger JC,
    7. et al.

    (2010) Gamma Knife stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 112, 758–765.